Binding of amyloid beta precursor protein to coagulation factor XIa in vivo may favour haemorrhagic stroke

Autor: Van Nostrand We, Meijers Jc, Joost Haan, Ross Ra, von dem Borne Pa, Bornebroek M

Publikováno v: Journal of neurology, 245(2), 111-115. D. Steinkopff-Verlag

Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D), caused by a mutation at codon 693 in the amyloid β precursor protein (βPP) gene, is clinically characterised by haemorrhagic strokes and dementia. The secreted forms βPP751 an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d2407221d47d89c0c6521fcec643fe4
https://doi.org/10.1007/s004150050188

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis

Autor: von dem Borne, PA, Meijers, JC, Bouma, BN

Publikováno v: Blood; October 1995, Vol. 86 Issue: 8 p3035-3042, 8p

The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide.

Autor: von dem Borne PA; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Kemps-Mols BM; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., de Wreede LC; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands., van Beek AA; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede, the Netherlands., van Lammeren D; Department of Hematology, Haga ziekenhuis, Den Haag, The Netherlands., Tijmensen J; Department of Hematology, Reinier de Graaf Gasthuis, Delft, the Netherlands., Sijs-Szabó A; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Oudshoorn MA; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Halkes CJM; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., van Balen P; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Marijt WAE; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Tjon JML; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Veelken H; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep; Vol. 65 (9), pp. 1270-1280. Date of Electronic Publication: 2024 May 06.

Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.

Autor: Baron F; GIGA-I3, Université de Liège et CHU de Liège, Liège, Belgium., Nagler A; Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Ramat-Gan, Israel., Galimard JE; EBMT Statistical Unit, Paris, France.; Department of Hematology, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Paris, France.; Sorbonne University, Paris, France., Sanz J; Hematology Department, University Hospital La Fe, Valencia, Spain., Versluis J; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Forcade E; Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Bordeaux, France., Chevallier P; Dept. D'Hematologie, CHU Nantes, Nantes, France., Sirvent A; Département d'Hématologie Clinique, CHU Lapeyronie, Montpellier, France., Anthias C; Royal Marsden Hospital, Leukaemia Myeloma Units, London, UK., Kuball J; Department of Haematology, University Medical Centre, Utrecht, The Netherlands., Furst S; Programme de Transplantation & Thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France., Rambaldi A; Department of Oncology and Hematology, University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Milan, Italy., Sierra J; Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain., von dem Borne PA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Gallego Hernanz MP; Hematologic Oncology and Cellular Therapy Department, CHU Poitiers, Poitiers, France., Cluzeau T; CHU Nice-Hôpital de l'ARCHET I, Hematologie Clinique, Nice, France., Robinson S; Department of Paediatric Oncology/BMT, Bristol Royal Hospital for Children, Bristol, UK., Raiola AM; Department of Haematology II, IRCCS Ospedale San Martino, Genova, Italy., Labussière-Wallet H; Hopital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France., Byrne JL; Nottingham University, Nottingham, UK., Malfuson JV; Hôpital D'instruction des Armées (HIA) PERCY, Service d'Hématologie, Clamart, France., Ruggeri A; Ospedale San Raffaele s.r.l. Haematology and BMT, Milan, Italy., Mohty M; EBMT Statistical Unit, Paris, France.; Department of Hematology, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Paris, France.; Sorbonne University, Paris, France., Ciceri F; Ospedale San Raffaele s.r.l. Haematology and BMT, Milan, Italy.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Jan; Vol. 204 (1), pp. 250-259. Date of Electronic Publication: 2023 Oct 02.